All lobbying filings

FORBES-TATE

Lobbying for ELI LILLY AND COMPANY FKA LILLY USA, LLC · Pharmaceutical Company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Indiana · House · Senate · $50,000.00 income · posted Apr 15, 2025

Official filing document

Bills named in this filing 2

HR 4818
Gas Pipeline Leak Detection and Repair Act of 2025
S 2407
Charting My Path for Future Success Act

Lobbying activity 2

Health Issues

Issues related to Insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program.

Medicare/Medicaid

Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4818/S. 2407 the Treat and Reduce Obesity Act of 2023.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.